Elisa
Lozano Esteban
Universidad de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Navarra (6)
2022
-
Impact of alternative splicing variants on liver cancer biology
Cancers, Vol. 14, Núm. 1
2018
-
Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib
Oncotarget, Vol. 9, Núm. 47, pp. 28474-28485
-
The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 4, pp. 1468-1477
2017
-
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma
Journal of Hepatology, Vol. 67, Núm. 1, pp. 72-83
2014
-
Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases
Gut, Vol. 63, Núm. 10, pp. 1658-1667
2012
-
No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors
Molecular Pharmaceutics, Vol. 9, Núm. 6, pp. 1693-1704